ArriVent Biopharma raised $150M Series A venture round, led by Hillhouse Capital Group.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$465M
Top Valuation
-
ArriVent Biopharma raised $150M in a Series A round.
The round was announced on 06/30/21.
The round was led by Hillhouse Capital Group.